Electrically Triggered Fluorescein and Dexamethasone Release from Conducting Polymer Hydrogels
Tissue Engineering Part A · 19.02.2026
DOI: 10.1177/19373341251373100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, online erschienen am 19.02.2026. Verfasst von Matthew S Horrocks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Materials Engineering, Faculty of Engineering, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Dexamethasone, Hydrogels, Fluorescein, Polymers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Spatially and temporally controlled drug delivery is an important field to address the limitations of conventional pharmaceutical administration. While many effective controlled drug delivery systems exist, the repertoire of systems that additionally present a beneficial mechanical environment to cells remains scarce. To address this, a comprehensive release study of fluorescein as a model drug, and the corticosteroid dexamethasone, from poly( N -isopropylacrylamide)/polypyrrole (pNIPAM/PPy) conducting polymer hydrogels is presented within this study. Cyclic voltammetry and scanning electron microscopy (SEM) indicated that having the pNIPAM hydrogel phase present and doping with drugs reduced PPy thickness and shifted/suppressed redox peaks to some degree but not enough to prevent release. Fluorescein release was initiated by constant reduction, with a maximum of 54.5 ± 6.8 µg/cm 2 from PPy films and 6.3 ± 1.1 µg/cm 2 from pNIPAM/PPy. The quantity of fluorescein released was shown to be tunable by modulating the charge passed during PPy electropolymerization. Fluorescein-loaded pNIPAM/PPy samples were capable of multiple cycles of depletion and reloading via re-incorporation through re-oxidation in a fluorescein solution. The stability of pNIPAM/PPy regarding drug release was demonstrated, with no difference in release profiles and quantities after soaking samples for 1, 8, and 15 days. Interestingly, constant reduction did not elicit release of dexamethasone, while a biphasic pulsed potential of ±0.8 V at 0.5 Hz was effective. Minimal leaching of dexamethasone without stimulation was shown, alongside a multi-day, multi-triggerable release profile upon short stimulations. pNIPAM/PPy conducting polymer hydrogels are a promising platform for on/off drug delivery, with a nondegrading matrix, minimal passive drug-leaching, and where the drug payload can be reloaded, all while providing a suitable mechanical environment to interface with living cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Materials Engineering, Faculty of Engineering, The University of Auckland, Auckland, New Zealand.
- MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington, New Zealand.
- School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
ORCID-Profile: Jenny Malmström
Zitieren
APA
Horrocks, M. S., Zhurenkov, K. E., Ting, M. S., Svirskis, D., & Malmström, J. (2026). Electrically Triggered Fluorescein and Dexamethasone Release from Conducting Polymer Hydrogels. Tissue Engineering Part A. https://doi.org/10.1177/19373341251373100
Vancouver
Horrocks MS, Zhurenkov KE, Ting MS, Svirskis D, Malmström J. Electrically Triggered Fluorescein and Dexamethasone Release from Conducting Polymer Hydrogels. Tissue Engineering Part A. 2026. doi:10.1177/19373341251373100
BibTeX
@article{Horrocks2026,
author = {Horrocks, Matthew S and Zhurenkov, Kirill E and Ting, Matthew S and Svirskis, Darren and Malmström, Jenny},
title = {Electrically Triggered Fluorescein and Dexamethasone Release from Conducting Polymer Hydrogels},
journal = {Tissue Engineering Part A},
year = {2026},
doi = {10.1177/19373341251373100}
}
EUVIMED